McCarty DJ, Kohn NN, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome” I. Clin Asp Ann Intern Med. 1962;56:711–37.
Canhao H, Fonseca JE, Leandro MJ, Romeu JC, Pimentão JB, Costa JT, et al. Cross-sectional study of 50 patients with calcium pyrophosphate dihydrate crystal arthropathy. Clin Rheumatol. 2001;20:119–22.
Scott JT. Copeman’s textbook of the rheumatic diseases. 5th ed. Edinburgh: Churchill Livingstone; 1978.
Resnick D. Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease. In: Hotokezaka Y, editor. Diagnosis of bone and joint disorders. 4th ed. Philadelphia: WB Saunders; 2002.
Pritzker KP, Phillips H, Luk SC, Koven IH, Kiss A, Houpt JB. Pseudotumor of temporomandibular joint: destructive calcium pyrophosphate dihydrate arthropathy. J Rheumatol. 1976;3:70–81.
Sissons HA, Steiner GC, Bonar F, May M, Rosenberg ZS, Samuels H, et al. Tumoral calcium pyrophosphate deposition disease. Skelet Radiol. 1989;18:79–877.
Ishida T, Dorfman HD, Bullough PG. Tophaceous pseudogout (tumoral calcium pyrophosphate dihydrate crystal deposition disease). Hum Pathol. 1995;26:587–93.
Abdelsayed RA, Said-Al-Naief N, Salguerio M, Holmes J, El-Mofty SK. Tophaceous pseudogout of the temporomandibular joint: a series of 3 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:369–75.
Grant GA, Wener MH, Yaziji H, Futran N, Bronner MP, Mandel N, et al. Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature. J Neurosurg. 1999;90:148–52.
Steinbach LS, Resnick D. Calcium pyrophosphate dihydrate crystal deposition disease revisited. Radiology. 1996;200:1–9.
Marsot-Dupuch K, Smoker WR, Gentry LR, Cooper KA. Massive calcium pyrophosphate dihydrate crystal deposition disease: a cause of pain of the temporomandibular joint. AJNR Am J Neuroradiol. 2004;25:876–9.
Kurihara K, Mizuseki K, Saiki T, Wakisaka H, Maruyama S, Sonobe J. Tophaceous pseudogout of the temporomandibular joint: report of a case. Pathol Int. 1997;47:578–80.
Nakagawa Y, Ishibashi K, Kobayashi K, Westesson PL. Calcium pyrophosphate deposition disease in the temporomandibular joint: report of two cases. J Oral Maxillofac Surg. 1999;57:1357–63.
Nardini-Guarda L, Piccoti F, Ferronato G, Manfredini D. Synovial chondromatosis of the temporomandibular joint: a case description with systematic literature review. Int J Oral Maxillofac Surg. 2010;39:745–55.
Kudoh K, Kudoh T, Tsuru K, Miyamoto Y. A case of tophaceous pseudogout of the temporomandibular joint extending to the base of the skull. Int J Oral Maxillofac Surg. 2017;46:355–9.
Hutton CW, Doherty M, Dieppe PA. Acute pseudogout of the temporomandibular joint: a report of three cases and review of the literature. Br J Rheumatol. 1987;26:51–2.
Aoyama S, Kino K, Amagasa T, Kayano T, Ichinose S, Kimijima Y. Differential diagnosis of calcium pyrophosphate dihydrate deposition of the temporomandibular joint. Br J Oral Maxillofac Surg. 2000;38:550–3.
Nicholas BD, Smith JL 2nd, Kellman RM. Calcium pyrophosphate deposition of the temporomandibular joint with massive bony erosion. J Oral Maxillofac Surg. 2007;65:2086–9.
Smolka W, Eggensperger N, Stauffer-Brauch EJ, Brekenfeld C, Iizuka T. Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint. Oral Dis. 2005;11:104–8.
Cottrell DA, Nierzwicki BL, Jacob GA, Lazow SK. Nontender mass in the parotid region. J Oral Maxillofac Surg. 2002;60:912–7.
